Keywords: potential, new, use, rituximab, cll, world, biotechnology

Potential new use for rituximab in CLL

Article | 13 October 2008

Print This

World biotechnology giant Genentech and USA-based Biogen Idec say that a global Phase III study of Rituxan (rituximab) with chemotherapy ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in